🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the levels of loteprednol etabonate (LE) in tear fluid following ...
Status
Completed
Location
Bausch & Lomb Research Clinic
Start Date
2013-01
Trial ID
NCT01736527
Treatments Being Tested
Amyotrophic Lateral Sclerosis (ALS) is the most common neurodegenerative di...
Status
Completed
Location
Ophthalmology Department, University Hospital of Tours, France
Start Date
2021-09-17
Trial ID
NCT04953286
The prevalence of Sjogren's syndrome (SS) in rheumatoid arthritis (RA) pati...
Status
Unknown
Location
CHU de Clermont-Ferrand
Start Date
2023-02-02
Trial ID
NCT05782049
Treatments Being Tested
This study aims to obtain the lacrimal fingerprint for frequent pathologies...
Status
Recruiting
Location
Université du Québec à Montréal (UQAM) - Department of Chemistry
Start Date
2020-02-01
Trial ID
NCT04198740
Treatments Being Tested
This Pilot Study is to investigate the tear proteins in a multitude of canc...
Status
Unknown
Location
Namida Lab
Start Date
2021-08-25
Trial ID
NCT05223218
Treatments Being Tested
Investigation of a tear-based, lab-developed biological test for breast can...
Status
Unknown
Location
Namida Lab
Start Date
2021-10-01
Trial ID
NCT05268224
Treatments Being Tested
This study aims to see if the amount of iron in tears is linked to how seve...
Status
Recruiting
Location
Changzheng Hospital
Start Date
2026-02-06
Trial ID
NCT07363824
Treatments Being Tested
The aim of the research was to examine the effect of oral care bundle appli...
Status
Completed
Location
Gül Güneş AKTAN
Start Date
2019-05-01
Trial ID
NCT06258603
Treatments Being Tested
The diagnosis of Alzheimer's disease (AD) relies on the detection of protei...
Status
Recruiting
Location
CHRU de Tours
Start Date
2025-07-09
Trial ID
NCT06661564
Primary acquired nasolacrimal duct obstruction (PANDO) is a lacrimal duct o...
Status
Recruiting
Location
Zhongshan Ophthalmic Center
Start Date
2025-09-08
Trial ID
NCT07154121
Treatments Being Tested